Lucia Nappi

1.7k total citations
78 papers, 734 citations indexed

About

Lucia Nappi is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Lucia Nappi has authored 78 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 40 papers in Surgery and 27 papers in Molecular Biology. Recurrent topics in Lucia Nappi's work include Testicular diseases and treatments (32 papers), Sarcoma Diagnosis and Treatment (19 papers) and Prostate Cancer Treatment and Research (10 papers). Lucia Nappi is often cited by papers focused on Testicular diseases and treatments (32 papers), Sarcoma Diagnosis and Treatment (19 papers) and Prostate Cancer Treatment and Research (10 papers). Lucia Nappi collaborates with scholars based in Canada, Italy and United States. Lucia Nappi's co-authors include Martin Gleave, Ladan Fazli, Craig R. Nichols, Christian Kollmannsberger, Luigi Formisano, Roberto Bianco, Roberta Rosa, Sabino De Placido, Bianca Maria Veneziani and Roberta Marciano and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Lucia Nappi

69 papers receiving 729 citations

Peers

Countries citing papers authored by Lucia Nappi

Since Specialization

Citations

This map shows the geographic impact of Lucia Nappi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucia Nappi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucia Nappi more than expected).

Fields of papers citing papers by Lucia Nappi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucia Nappi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucia Nappi. The network helps show where Lucia Nappi may publish in the future.

Co-authorship network of co-authors of Lucia Nappi

This figure shows the co-authorship network connecting the top 25 collaborators of Lucia Nappi. A scholar is included among the top collaborators of Lucia Nappi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucia Nappi. Lucia Nappi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer 2025 ·JCO Clinical Cancer Informatics ·(unknown), (unknown), (unknown), Ka Mun Nip, (unknown), Arman Rahmim, Robert H. Bell, Corinne Maurice‐Dror, Maryam Soleimani, Kim Chi, Bernhard J. Eigl, Craig R. Nichols, Christian Kollmannsberger, Ren Yuan, Lucia Nappi	1
2	DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2 2024 ·Communications Biology ·(unknown), Heidi Kaljunen, Lucia Nappi, Ladan Fazli, Sonia H.Y. Kung, Jaana M. Hartikainen, Ville Paakinaho, (unknown), Kirsi Rilla, Marjo Malinen, Petri I. Mäkinen, Seppo Ylä‐Herttuala, Amina Zoubeidi, Yuzhuo Wang, Martin Gleave, Mikko Hiltunen, Kirsi Ketola	8
3	Evaluating the use of circulating tumor DNA (ctDNA) in patients with urothelial cancer in the context of FGFR-targeted therapy. 2023 ·Journal of Clinical Oncology ·Elena Schönlau, David C. Müller, Gillian Vandekerkhove, Andrew J. Murtha, Jack V. W. Bacon, (unknown), (unknown), Sunil Parimi, Krista Noonan, Naveen S. Basappa, Jenny J. Ko, Daygen L. Finch, Nimira Alimohamed, Tarek A. Bismar, Lucia Nappi, Matti Annala, Cecily Q. Bernales, Kim N., Alexander W. Wyatt, Bernhard J. Eigl	0
4	Primary Mediastinal Germ Cell Tumors: A Thorough Literature Review 2023 ·Biomedicines ·(unknown), Lucia Nappi	8
5	Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey−Holden prostate cancer academy meeting 2022 ·The Prostate ·Andrea K. Miyahira, Jessica E. Hawley, Remi Adelaiye‐Ogala, Jérémie Calais, Lucia Nappi, Ravi B. Parikh, Tyler M. Seibert, Elizabeth V. Wasmuth, Xiao X. Wei, Kenneth J. Pienta, Howard R. Soule	2
6	Testicular cancer survivorship: Long-term toxicity and management 2022 ·Canadian Urological Association Journal ·(unknown), Lori Wood, Robert J. Hamilton, (unknown), Piotr Czaykowski, (unknown), Andrew Matthew, Jason Izard, Peter Chung, Lucia Nappi, Jennifer M. Jones, Denis Soulières, Armen Aprikian, Nicholas Power, Christina Canil	12
7	Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade 2022 ·Frontiers in Oncology ·Jean‐Michel Lavoie, (unknown), Elizabeth A. Chavez, Lucia Nappi, Daniel Khalaf, Christian Kollmannsberger, Kim N., Andrew P. Weng, Christian Steidl, Bernhard J. Eigl, Michael Nissen	3
8	SEMS trial: Result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma. 2021 ·Journal of Clinical Oncology ·Siamak Daneshmand, Clint Cary, Timothy A. Masterson, Lawrence Einhorn, Stephen A. Boorjian, Christian Kollmannsberger, Anne Schuckman, (unknown), Peter C. Black, Aditya Bagrodia, Eila C. Skinner, Mehrdad Alemozaffar, Timothy C. Brand, Scott E. Eggener, Phillip M. Pierorazio, Kelly Stratton, Lucia Nappi, Craig R. Nichols, Brian Hu	21
9	Effectiveness of first-line abiraterone versus enzalutamide among patients ≥80 years of age with metastatic castration-resistant prostate cancer: A retrospective propensity score–weighted comparative cohort study 2021 ·European Journal of Cancer ·Maryam Soleimani, (unknown), Katherine Sunderland, Werner J. Struss, Bernhard J. Eigl, Lucia Nappi, Christian Kollmannsberger, Daygen L. Finch, Krista Noonan, Joanna Vergidis, Muhammad Zulfiqar, Kim N., Daniel Khalaf	11
10	Avelumab and Axitinib Combination Therapy for the Treatment of Advanced Renal Cell Carcinoma 2020 ·Future Oncology ·Maryam Soleimani, Lucia Nappi, Christian Kollmannsberger	5
11	LIN28B promotes the development of neuroendocrine prostate cancer 2020 ·Journal of Clinical Investigation ·(unknown), Yu Gan, Tingting Feng, Yinan Li, Ning Xie, (unknown), Ahn R. Lee, Xufeng Chen, Lucia Nappi, Bo Han, Ladan Fazli, Jiaoti Huang, Martin Gleave, Xuesen Dong	72
12	MicroRNAs as Biomarkers for Germ Cell Tumors 2019 ·Urologic Clinics of North America ·Lucia Nappi, Craig R. Nichols	22
13	Loss of Nuclear Functions of HOXA10 Is Associated With Testicular Cancer Proliferation 2018 ·Frontiers in Oncology ·Ruiqi Chen, Haolong Li, Yinan Li, Ladan Fazli, Martin Gleave, Lucia Nappi, Xuesen Dong	15
14	Biological assessment of viable germ cell tumor (VT) in patients (pts) with seminoma (S) and non-seminoma (S) using miR371 2017 ·Annals of Oncology ·Lucia Nappi, (unknown), Ladan Fazli, K.N. Chi, Bernhard J. Eigl, Craig Nichols, Martin Gleave, Christian Kollmannsberger	1
15	Outcomes of peri-operative chemotherapy (PO-CT) for locally advanced penile squamous cell carcinoma (LA-PSCC): results from a multicenter analysis 2016 ·Annals of Oncology ·Andrea Necchi, Gregory R. Pond, Daniele Raggi, Sarah R. Ottenhof, Simon Horenblas, Vincent Khoo, (unknown), Axel Heidenreich, Bernhard J. Eigl, Lucia Nappi, Kazuya Matsumoto, Ulka N. Vaishampayan, (unknown), Patrizia Giannatempo, Daniel M. Geynisman, Mirko Preto, (unknown), Matthew I. Milowsky, Giuseppe Di Lorenzo, Guru Sonpavde	0
16	Hsp27 Inhibition with OGX-427 Sensitizes Non–Small Cell Lung Cancer Cells to Erlotinib and Chemotherapy 2015 ·Molecular Cancer Therapeutics ·Barbara Lelj‐Garolla, Masafumi Kumano, Eliana Beraldi, Lucia Nappi, Palma Rocchi, Diana Beşliu-Ionescu, Ladan Fazli, Amina Zoubeidi, Martin Gleave	43
17	Correlation between plasmatic levels of vitamin D and testicular cancer 2015 ·Annals of Oncology ·Lucia Nappi, V. Damiano, Margaret Ottaviano, Pasquale Rescigno, (unknown), (unknown), (unknown), Elide Matano, Giovannella Palmieri	3
18	Effectiveness of somatostatin analogs plus prednisone in aggressive histotype and advanced stage of thymic epithelial tumors 2015 ·Annals of Oncology ·Margaret Ottaviano, V. Damiano, Lucia Nappi, Pasquale Rescigno, Liliana Montella, (unknown), Silvana Del Vecchio, (unknown), Claudia von Arx, Elide Matano, Giovannella Palmieri	2
19	Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma 2013 ·OncoImmunology ·Roberta Rosa, Vincenzo Damiano, Luigi Formisano, Lucia Nappi, Roberta Marciano, Bianca Maria Veneziani, Sabino De Placido, Roberto Bianco	4
20	Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models 2012 ·Clinical Cancer Research ·Roberta Rosa, Roberta Marciano, Umberto Malapelle, Luigi Formisano, Lucia Nappi, Claudia D’Amato, Valentina Damato, Vincenzo Damiano, Gabriella Marfè, Silvana Del Vecchio, Antonella Zannetti, Adelaide Greco, Alfonso De Stefano, Chiara Carlomagno, Bianca Maria Veneziani, Giancarlo Troncone, Sabino De Placido, Roberto Bianco	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact